Viewing Study NCT01167868


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-01-22 @ 2:18 PM
Study NCT ID: NCT01167868
Status: COMPLETED
Last Update Posted: 2013-02-07
First Post: 2010-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None fostamatinib disodium View
None FosD View
None Japanese View
None Healthy volunteers View
None Phase 1 View
None Single and Multiple Ascending Dose Study View
None Healthy Japanese volunteers View
None Healthy White volunteers View